Climb Bio, Inc. (CLYM)
10.19
-0.35
(-3.32%)
USD |
NASDAQ |
Oct 23, 16:00
10.34
+0.15
(+1.47%)
After-Hours: 20:00
Climb Bio Market Cap : 585.28M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 585.28M |
| October 22, 2026 | 605.38M |
| October 21, 2026 | 624.33M |
| October 20, 2026 | 620.31M |
| October 19, 2026 | 558.86M |
| October 16, 2026 | 564.02M |
| October 15, 2026 | 626.63M |
| October 14, 2026 | 591.02M |
| October 13, 2026 | 592.17M |
| October 12, 2026 | 622.04M |
| October 09, 2026 | 631.80M |
| October 08, 2026 | 623.76M |
| October 07, 2026 | 615.14M |
| October 06, 2026 | 613.42M |
| October 05, 2026 | 634.67M |
| October 02, 2026 | 628.35M |
| October 01, 2026 | 635.82M |
| September 30, 2026 | 658.79M |
| September 29, 2026 | 660.52M |
| September 28, 2026 | 674.30M |
| September 25, 2026 | 669.71M |
| September 24, 2026 | 682.92M |
| September 23, 2026 | 719.10M |
| September 22, 2026 | 816.17M |
| September 21, 2026 | 783.43M |
| Date | Value |
|---|---|
| September 18, 2026 | 806.98M |
| September 17, 2026 | 807.55M |
| September 16, 2026 | 810.43M |
| September 15, 2026 | 798.94M |
| September 14, 2026 | 836.27M |
| September 11, 2026 | 818.47M |
| September 10, 2026 | 858.67M |
| September 09, 2026 | 864.42M |
| September 08, 2026 | 913.24M |
| September 04, 2026 | 891.41M |
| September 03, 2026 | 838.00M |
| September 02, 2026 | 864.42M |
| September 01, 2026 | 851.21M |
| August 31, 2026 | 788.60M |
| August 28, 2026 | 836.85M |
| August 27, 2026 | 864.99M |
| August 26, 2026 | 923.58M |
| August 25, 2026 | 1.025B |
| August 24, 2026 | 941.96M |
| August 21, 2026 | 992.50M |
| August 20, 2026 | 977.57M |
| August 19, 2026 | 995.95M |
| August 18, 2026 | 998.82M |
| August 17, 2026 | 1.002B |
| August 14, 2026 | 937.93M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Korsana Biosciences, Inc. | 19.04M |
| Cullinan Therapeutics, Inc. | 927.58M |
| Q32 Bio, Inc. | 205.32M |
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
Market Cap Related Metrics
| PEG Ratio | -0.6379 |
| Price to Book Value | 2.443 |
| Price | 10.19 |
| Earnings Yield | -8.12% |
| PEGY Ratio | -0.6379 |